• GSK2606414: Practical PERK Inhibition Workflows

  2026-08-28

  GSK2606414 gives researchers a selective way to test whether PERK signaling drives translational shutdown, ER-stress adaptation, fibrosis, or tumor phenotypes. This workflow-focused guide connects dose design, pathway readouts, disease-model validation, and troubleshooting to practical PERK inhibitor experiments.

• PF-562271 HCl: FAK/Pyk2 Inhibitor Guide

  2026-08-28

  PF-562271 HCl is a selective, ATP-competitive and reversible FAK/Pyk2 inhibitor for cancer research. Its reported nanomolar potency and FAK phosphorylation inhibition support studies of tumor growth, metastasis, and signaling, but the compound should not be treated as a direct ERK inhibitor or as proof of an IFNγ-specific mechanism.

• AMPK, ULK1, and Autophagy Under Energy Stress

  2026-08-27

  The reference study challenges the prevailing view that AMPK uniformly activates autophagy during energy shortage. Its evidence indicates that AMPK suppresses ULK1-dependent autophagy initiation during acute energy stress while protecting autophagy machinery from caspase-mediated degradation, preserving the capacity for recovery.

• Fucoidan: Applied Workflows for Cancer Research

  2026-08-27

  Build reproducible Fucoidan assays around formulation control, staged apoptosis measurements, and immune-cell readouts rather than relying on a single viability endpoint. This guide also translates a herpesvirus membrane-fusion discovery into a carefully bounded antiviral assay strategy without implying that Fucoidan targets CLCC1.

• SR 11302: AP-1 Signaling in Cancer Research

  2026-08-26

  SR 11302 is an AP-1 transcription factor inhibitor for dissecting tumor-promoting and inflammatory gene programs. This guide connects cancer-cell phenotypes with TLR4–macrophage research while defining practical assay controls, limitations, and interpretation strategies.

• Macrophage EV miR-660 in Breast Cancer Metastasis

  2026-08-26

  The reference study identifies a macrophage-to-tumor communication route in which extracellular-vesicle-delivered miR-660 suppresses KLHL21 and releases restraint on the IKKβ/NF-κB p65 pathway, increasing breast cancer cell migration and invasion. Its main value is mechanistic: it connects tumor-associated macrophage cargo, a defined RNA–protein interaction, and metastasis-related phenotypes while clarifying the controls needed for translational follow-up.

• KX2-391 Dihydrochloride: Mechanism to Assay Design

  2026-08-25

  KX2-391 dihydrochloride, also known as Tirbanibulin dihydrochloride, connects Src, tubulin, and HBV transcription biology. This article translates its mechanism into evidence-led assay decisions while distinguishing validated findings from exploratory applications.

• Anp32e and TGF-β/Smad3 in Renal Fibrosis

  2026-08-25

  The 2022 study by Wei et al. identifies Anp32e as a functional promoter of renal interstitial fibrosis rather than merely a marker associated with injury. Across IgA nephropathy tissue, UUO kidneys, and proximal tubular cells, the authors link Anp32e to TGF-β1/Smad3 activation and show that pharmacological pathway blockade reverses fibrotic protein accumulation.

• SP600125 for Reliable JNK-Linked Cell Assays

  2026-08-24

  Learn how SP600125 (SKU A4604) can help researchers separate JNK-dependent signaling from nonspecific cytotoxicity in viability, apoptosis, inflammation, and proliferation workflows. This scenario-based guide covers concentration selection, DMSO handling, controls, interpretation, and practical vendor evaluation.

• CMA Decline Drives Age-Related Muscle Myopathy

  2026-08-24

  This study identifies chaperone-mediated autophagy (CMA) as an active regulator of skeletal-muscle homeostasis rather than a passive lysosomal clearance pathway. Using reporter mice, muscle-specific Lamp2a deletion, proteomics, and human tissue analysis, the authors link age-related CMA loss to defective SERCA turnover, calcium dysregulation, mitochondrial changes, and progressive myopathy.

• DMB Blocks IL-1β Maturation via TLR4–Mitochondria

  2026-08-23

  The reference study identifies Demethyleneberberine (DMB) as an inhibitor of inflammation-linked IL-1β maturation through modulation of TLR4–mitochondria signaling. Using a DSS-induced ulcerative colitis model, macrophage systems, genetic controls, and mitochondrial perturbation experiments, it connects mitochondrial homeostasis with the inflammatory maturation step rather than treating cytokine suppression as a nonspecific endpoint.

• Dual-Action p38α Inhibitors and Dephosphorylation

  2026-08-22

  The reference preprint shows that selected p38α kinase inhibitors can do more than occupy the catalytic site: they can also accelerate WIP1-mediated dephosphorylation by reshaping the kinase activation loop. Structural and biochemical results establish a mechanism in which inhibitor-driven conformational control exposes the activation-loop phospho-threonine, suggesting a route toward more potent and selective kinase-directed pharmacology.

• Losmapimod: A Smarter p38 MAPK Assay Strategy

  2026-08-22

  Losmapimod and GW856553X offer a powerful way to study p38α/β-driven inflammation signaling modulation. This article focuses on a practical, mechanism-aware assay strategy that separates direct kinase inhibition from phosphatase-coupled dephosphorylation and improves interpretation across vascular, hypertension, and COPD research.

• Nocodazole for Cytoskeletal Entry Assays

  2026-08-21

  Nocodazole is a reversible microtubule polymerization inhibitor that can do more than arrest mitosis. This article explains how to use it as a causal perturbation in host–pathogen entry assays, while separating microtubule-dependent trafficking from cytotoxicity and impaired pathogen replication.

• GSK2606414 in TMAO-Driven Liver Disease Research

  2026-08-20

  Discover how the PERK inhibitor GSK2606414 can turn TMAO-induced liver injury from an observational model into a mechanistically testable ER stress system. This guide connects PERK biology, assay design, pharmacological controls, and translational interpretation.

546 records 6/37 page Previous Next First page 上5页 678910 下5页 Last page